Dr. Basile Njei, an esteemed figure in Hepatology, has been honored with the Future Science Leader Award for his groundbreaking contributions to the field. Serving as the Co-Director of the International Medicine Program at Yale University in the United States, Dr. Njei embodies excellence in research and clinical practice. His dedication to advancing liver health through innovative approaches has earned him widespread recognition 🏅. With a commitment to education and global collaboration, Dr. Njei continues to inspire future generations of medical professionals while making significant strides in the fight against liver diseases.
Profile
Google Scholar
Education 🎓
Basile Njei received his Bachelor of Science in Biomedical Sciences from the University of Yaoundé 1, Cameroon in June 2005, followed by a Doctor of Medicine (M.D.) degree from the same institution in July 2008. He pursued further education at the University of Edinburgh, United Kingdom, earning a Master of Public Health (M.P.H.) in Epidemiology/Biostatistics in November 2009. Subsequently, he completed his residency in Internal Medicine at the University of Connecticut, Hartford, CT in June 2014. He then undertook fellowships in Gastroenterology/Hepatology and Clinical Research at Yale School of Medicine and Veterans Affairs, West Haven, CT, from June 2017 to June 2022. He capped his academic journey with a Ph.D. in Investigative Medicine from Yale University in December 2022.
Experience 👨🔬
Basile Njei has held various positions in academia and clinical practice. Currently, he serves as an Instructor in Digestive Diseases at Yale University, New Haven, CT, since 2023. Concurrently, he works as a Staff Gastroenterologist at Veterans Affairs, West Haven, CT, since 2023. His previous roles include Postdoctoral Research Fellow at Yale University and Veterans Affairs from 2021 to 2022, and Staff Gastroenterologist at UPMC-Western Maryland, Cumberland, MD, from 2018 to 2022.
Research Interests 🔬
Basile Njei’s research interests revolve around the clinical and genetic determinants of chronic liver diseases, with a focus on non-alcoholic fatty liver disease (NAFLD). He is particularly interested in leveraging artificial intelligence (AI) and epidemiologic techniques to study disease patterns, prognosis, and interventions in hepatology. His ongoing and recent projects encompass genome-wide association studies, AI models for disease prediction, and epidemiologic trends in liver cancer and COVID-19-related liver sequelae.
Awards 🏆
Basile Njei has garnered recognition for his contributions to research and clinical practice. He has received prestigious awards such as the Harvard Global Clinical Research Scholar (2022), University of Oxford Artificial Intelligence Scholar (2022), and Yale Center for Clinical Investigation Scholar (2021). Additionally, he has been honored with awards like the Samuel Kushlan Award for Excellence in Research (2017) and multiple science awards for research excellence during his academic journey.
Publications Top Notes 📚
“Artificial Intelligence in Medical Imaging for Cholangiocarcinoma Diagnosis” (2023), cited in J Gastroenterol Hepatol.
“Epidemiology, Diagnosis, and Treatments of Viral Hepatitis B, C and D” (2019), featured in Med Care.
“Interventions and Outcomes in Patients with Cirrhosis and NAFLD” (2019), published in Gastroenterology.
“Diagnosis of Malignant Biliary Strictures in Primary Sclerosing Cholangitis” (2017), highlighted in Gastrointest Endosc.